Trial Profile
Atorvastatin + antioxidants in asymptomatic patients with elevated coronary calcification
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 08 Jan 2014
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Ascorbic acid; Tocopherol
- Indications Coronary artery disease; Coronary disorders
- Focus Biomarker; Therapeutic Use
- Acronyms SFHS
- 20 Nov 2013 Secondary analysis presented at the 86th Annual Scientific Sessions of the American Heart Association.
- 05 Nov 2010 New trial record.